Tenax Therapeutics, Inc. Stock Performance

Open $1.91	Prev. Close $1.85	Circuit Range N/A
Day Range $1.85 - $1.97	Year Range $1.32 - $19.19	Volume 2,08,501
Average Traded $1.91

Tenax Therapeutics, Inc. Share Price Today

As of 19 September 2026, Tenax Therapeutics, Inc.'s share price is $1.90. The stock opened at $1.91, compared to its previous close of $1.85. During today's trading session, Tenax Therapeutics, Inc.'s share price traded between $1.85 and $1.97, with an average price of $1.91. Over the past 52 weeks, the stock has recorded a high of $19.19 and a low of $1.32. In terms of performance, Tenax Therapeutics, Inc.'s share price has declined by 88.15% over the last six months and is down 75.13% on a year-on-year basis.

Tenax Therapeutics, Inc. Share Price Chart

$1.85$1.97

Tenax Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap $74.51M	PE Ratio (TTM) -1.42	Dividend Yield N/A
EPS (TTM) $-1.34	Revenue (TTM) N/A	Return On Equity (TTM) -54.19%
Profit Margin N/A	Debt to Equity 0.07	Quarterly Earnings Growth YoY -499.04%

Tenax Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit	$3.80M	$3.58M	$3.96M	-$10.41M	-$10.85M	-$15.80M
Net Profit Margin	N/A	N/A	N/A	N/A	N/A	N/A
Income Change	N/A	-5.87%	10.76%	-362.80%	-4.22%	-45.70%

Tenax Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars	2021	2022	2023	2024	2025
Revenue	N/A	N/A	N/A	N/A	N/A
Net Profit	-$32.47M	-$11.05M	$7.71M	-$17.60M	-$52.60M
Net Profit Margin	N/A	N/A	N/A	N/A	N/A
Income Change	N/A	65.98%	169.79%	-328.28%	-198.82%

About Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc., a clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.

Tenax Therapeutics, Inc. Historical Returns

Month	Open	Close	Change %
Sep 2026	$1.78	$1.91	-13.01%
Aug 2026	$13.97	$2.19	-84.00%
Jul 2026	$14.43	$13.69	-6.01%
Jun 2026	$11.70	$14.56	+22.25%
May 2026	$12.95	$11.91	-9.08%
Apr 2026	$16.17	$13.10	-18.28%
Mar 2026	$11.76	$16.03	+33.75%
Feb 2026	$12.48	$11.98	-3.42%
Jan 2026	$12.10	$12.41	+1.97%
Dec 2025	$8.92	$12.17	+29.19%
Nov 2025	$7.26	$9.42	+30.65%
Oct 2025	$7.61	$7.21	-5.63%

TENX Share Price FAQs

What is Tenax Therapeutics, Inc. share price today?

Tenax Therapeutics, Inc. share price today is $1.90 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Tenax Therapeutics, Inc. stock?

The 52 week high of Tenax Therapeutics, Inc. stock is $19.19, while the 52 week low is $1.32 as of 19 Sep '26.

What is TENX's market capitalisation today?

TENX market capitalisation is $74.51M as of September 19, 2026, at 3:50 pm IST.

What is TENX's net income for the last quarter?

TENX's net income for the last quarter is -0.02B USD.

What is the 5 year returns of TENX?

The 5 year returns of TENX is -99.93% as on 19 Sep '26.

What is the high & low stock price of TENX today?

TENX stock price hit a high of $1.97 and low of $1.85 as of 19 Sep '26.

Can I buy TENX shares in India?

Yes. You can buy TENX in India by opening an international trading account.